Trial record 1 of 1 for:    NCT01533948
Previous Study | Return to List | Next Study

Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery

This study has been terminated.
(low accrual)
Sponsor:
Collaborators:
National Cancer Institute (NCI)
National Comprehensive Cancer Network
Information provided by (Responsible Party):
Roswell Park Cancer Institute
ClinicalTrials.gov Identifier:
NCT01533948
First received: January 18, 2012
Last updated: May 31, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)